{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:56:42Z","timestamp":1760061402961},"reference-count":31,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Archives of Oral Biology"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1016\/j.archoralbio.2004.05.003","type":"journal-article","created":{"date-parts":[[2004,6,25]],"date-time":"2004-06-25T12:30:56Z","timestamp":1088166656000},"page":"895-901","source":"Crossref","is-referenced-by-count":7,"title":["Evaluation of acetaminophen P-glycoprotein-mediated salivary secretion by rat submandibular glands"],"prefix":"10.1016","volume":"49","author":[{"given":"Paula","family":"Schaiquevich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niselman","family":"Viviana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tumilasci","family":"Omar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rubio","family":"Modesto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.archoralbio.2004.05.003_BIB1","first-page":"83","article-title":"Saliva-plasma drug concentration ratios during absorption: Theoretical considerations and pharmacokinetic implications","volume":"57","author":"Posti","year":"1982","journal-title":"Pharm. Acta Helv."},{"key":"10.1016\/j.archoralbio.2004.05.003_BIB2","unstructured":"Fagiolino P, V\u00e1zquez M. Bioequivalence study of acetaminophen in saliva. Eur J Drug Metab Pharmacokinet 1994:164\u20138 [special issue]."},{"key":"10.1016\/j.archoralbio.2004.05.003_BIB3","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.2042-7158.1973.tb10042.x","article-title":"Salivary excretion of acetaminophen in man","volume":"25","author":"Glynn","year":"1973","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.archoralbio.2004.05.003_BIB4","first-page":"27","article-title":"Formulation and evaluation of sustained release acetaminophen tablets","volume":"6","author":"Ahmed","year":"1981","journal-title":"J. Clin. Hosp. Pharm."},{"key":"10.1016\/j.archoralbio.2004.05.003_BIB5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2125.1982.tb04944.x","article-title":"A comparative study of saliva and serum acetaminophen levels using simple spectrophotometric method","volume":"14","author":"Adithan","year":"1982","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.archoralbio.2004.05.003_BIB6","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.2042-7158.1987.tb06967.x","article-title":"Salivary secretion of acetaminophen in man","volume":"39","author":"Kamali","year":"1987","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.archoralbio.2004.05.003_BIB7","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1365-2125.1991.tb05580.x","article-title":"A comparison of serum and saliva acetaminophen concentrations","volume":"31","author":"Smith","year":"1991","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.archoralbio.2004.05.003_BIB8","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/bja\/85.4.512","article-title":"Pharmacokinetics of rectal acetaminophen after repeated dosing in children","volume":"85","author":"Hahn","year":"2000","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.archoralbio.2004.05.003_BIB9","unstructured":"Ritschel W, Kearns GL. Excretion and clearance of drugs. Handbook of basic pharmacokinetics: Including clinical applications. 5th ed. Washington, DC: AAPS; 1999. p. 204\u201320."},{"key":"10.1016\/j.archoralbio.2004.05.003_BIB10","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/0731-7085(95)01303-3","article-title":"Assay of paracetamol and its metabolites in urine, plasma and saliva of children with chronic liver disease","volume":"13","author":"Al-Obaidy","year":"1995","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.archoralbio.2004.05.003_BIB11","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/jps.2600800911","article-title":"Multiple-dose acetaminophen pharmacokinetics","volume":"80","author":"Sahajwalla","year":"1991","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.archoralbio.2004.05.003_BIB12","first-page":"173","article-title":"Post-prandial reabsorption of acetaminophen","volume":"19","author":"Vazquez","year":"1994","journal-title":"Eur. J. Drug. Metab. Pharmacokinet"},{"key":"10.1016\/j.archoralbio.2004.05.003_BIB13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2125.1996.tb00157.x","article-title":"Acetaminophen and its metabolites in saliva and plasma in chronic dialysis patients","volume":"41","author":"Lee","year":"1996","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.archoralbio.2004.05.003_BIB14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/bdd.316","article-title":"Importance of entero-salivary recirculation in acetaminophen pharmacokinetics","volume":"23","author":"Schaiquevich","year":"2002","journal-title":"Biopharm. Drug. Dispos."},{"key":"10.1016\/j.archoralbio.2004.05.003_BIB15","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0003-9969(01)00012-7","article-title":"P-glycoprotein expression in human major and minor salivary glands","volume":"46","author":"Uematsu","year":"2001","journal-title":"Arch. Oral. Biol."},{"key":"10.1016\/j.archoralbio.2004.05.003_BIB16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0003-9969(02)00159-0","article-title":"Expression of ATP-binding cassette transporter in human salivary ducts","volume":"48","author":"Uematsu","year":"2003","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.archoralbio.2004.05.003_BIB17","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1592\/phco.21.9.778.34558","article-title":"Pharmacokinetic and pharmacodynamic implications of P-glycoprotein modulation","volume":"21","author":"Matheny","year":"2001","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.archoralbio.2004.05.003_BIB18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1073\/pnas.84.1.265","article-title":"Expression of multidrug resistance gene in human tumors and tissues","volume":"84","author":"Fojo","year":"1987","journal-title":"Proc. Natl. Acad Sci. U.S.A."},{"issue":"Suppl","key":"10.1016\/j.archoralbio.2004.05.003_BIB19","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1007\/s002800051055","article-title":"Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein","volume":"40","author":"Sikic","year":"1997","journal-title":"Cancer Chemother Phamacol."},{"key":"10.1016\/j.archoralbio.2004.05.003_BIB20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev.pharmtox.39.1.361","article-title":"Biochemical, cellular and pharmacological aspects of the multidrug transporter","volume":"39","author":"Ambudkar","year":"1999","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.archoralbio.2004.05.003_BIB21","doi-asserted-by":"crossref","first-page":"7735","DOI":"10.1073\/pnas.84.21.7735","article-title":"Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues","volume":"84","author":"Thiebaut","year":"1987","journal-title":"Proc. Natl. Acad Sci. U.S.A."},{"key":"10.1016\/j.archoralbio.2004.05.003_BIB22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0009-9236(97)90027-8","article-title":"Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine","volume":"62","author":"Lown","year":"1997","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.archoralbio.2004.05.003_BIB23","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1172\/JCI118214","article-title":"Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin","volume":"96","author":"Schinkel","year":"1995","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.archoralbio.2004.05.003_BIB24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.5414\/CPP38161","article-title":"P-glycoprotein inhibitor erythromycin increases oral bioavailability of talinol in humans","volume":"38","author":"Schwarz","year":"2000","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.archoralbio.2004.05.003_BIB25","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0163-7258(96)00196-9","article-title":"Tachykinins in the gut. Part II. Roles in neural excitation, secretion and inflammation","volume":"73","author":"Holzer","year":"1997","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.archoralbio.2004.05.003_BIB26","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1177\/00220345810600060501","article-title":"Stimulatory and inhibitory effects of substance P on rat submandibular secretion","volume":"60","author":"Martinez","year":"1981","journal-title":"J. Dent Res."},{"key":"10.1016\/j.archoralbio.2004.05.003_BIB27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1748-1716.1991.tb09068.x","article-title":"On the non-adrenergic, non-cholinergic contribution to the parasympathetic nerve-evoked secretion of parotid saliva in the rat","volume":"141","author":"Mansson","year":"1991","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.archoralbio.2004.05.003_BIB28","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1177\/00220345860650121001","article-title":"Effects of substance P and substance P antagonists on rat salivary secretion","volume":"65","author":"Bobyock","year":"1986","journal-title":"J. Dent Res."},{"key":"10.1016\/j.archoralbio.2004.05.003_BIB29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF03189360","article-title":"Acetaminophen presystemic biotransformation versus bioavailability in therapeutical","volume":"23","author":"Goicoechea","year":"1998","journal-title":"Eur. J. Drug. Metab. Pharmacokinet"},{"key":"10.1016\/j.archoralbio.2004.05.003_BIB30","first-page":"407","article-title":"Glucuronidation and biliary excretion of acetaminophen in rats","volume":"228","author":"Hjelle","year":"1984","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.archoralbio.2004.05.003_BIB31","first-page":"14","article-title":"Dose- and time-dependent elimination of acetaminophen in rats: Pharmacokinetic implications of cosubstrate depletion","volume":"219","author":"Galinsky","year":"1981","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Archives of Oral Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003996904001062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003996904001062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T17:22:57Z","timestamp":1549473777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003996904001062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S0003996904001062"],"URL":"https:\/\/doi.org\/10.1016\/j.archoralbio.2004.05.003","relation":{},"ISSN":["0003-9969"],"issn-type":[{"value":"0003-9969","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}